|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 |
| (11) | Number of the document | 1951757 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06825618.9 |
| Date of filing the European patent application | 2006-10-06 | |
| (97) | Date of publication of the European application | 2008-08-06 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/039306 |
| Date | 2006-10-06 |
| (87) | Number | WO 2007/044616 |
| Date | 2007-04-19 |
| (30) | Number | Date | Country code |
| 724624 P | 2005-10-06 | US | |
| 737998 P | 2005-11-18 | US | |
| 750697 P | 2005-12-15 | US | |
| 776598 P | 2006-02-24 | US | |
| 745536 P | 2006-04-25 | US |
| (72) |
LAZAR, Gregory, Alan, US
DESJARLAIS, John, R., US
HAMMOND, Philip, W., US
CARMICHAEL, David, F., US
CHEN, Bao-lu, US
CHU, Seung, Y., US
KARKI, Sher, Bahadur, US
KUNKEL, Lori, US
|
| (73) |
Xencor, Inc.,
111 W. Lemon Avenue, Monrovia, CA 91016,
US
|
| (54) | OPTIMIZED ANTI-CD30 ANTIBODIES |
| OPTIMIZED ANTI-CD30 ANTIBODIES |